-- Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis.
North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagnosed with AML and 10,590 may die of the disease. About one-third of these AML patients will have a FLT3 gene mutation.
The Global Rydapt market is valued at 150 million US$ in 2018 and will reach 560 million US$ by the end of 2025, growing at a CAGR of 21.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Rydapt market based on company, product type, end user and key regions.
Access more details about this report at: https://www.themarketreports.com/report/global-rydapt-market-insights-forecast-to-2025
Objectives of Global Rydapt Market report are:
• To understand the global Rydapt market size (value & volume) by companies, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025
• To get the in-depth knowledge of Rydapt market by identifying its various segments and sub-segments
• To obtain detailed information about the key factors influencing the growth of the market and study of various parameters effective the market like growth potential, opportunities, drivers, industry-specific challenges and risks
• Focuses on the key global Rydapt market companies, comparing their sales volume, value, market share, market competitive landscape and recent developments
• To estimate the sales volume and value of Rydapt market / submarkets, with respect to key regions
• To identify competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Purchase this premium research report at: https://www.themarketreports.com/report/buy-now/1325614
Key companies profiled in this report are Novartis and more. Each company is profiled in the terms of company basic details, business overview, sales, revenue, gross margin, products, recent development, etc. Apart from segmentation by companies, it is also segmented by product types (growth rate, sales, revenue, price, regional analysis, sales & revenue forecast, etc.) and by applications (growth rate, segmentation by end users, regional analysis, estimated forecast, etc).
Market segment by Regions/Countries, this report covers:
• North America (United States, Canada, Mexico)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam)
• Europe (Germany, France, UK, Italy, Russia)
• Central & South America (Brazil, Rest of Central & South America)
• Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa)
Inquire further about this report at: https://www.themarketreports.com/report/ask-your-query/1325614
Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315
Website: https://www.themarketreports.com/report/global-rydapt-market-insights-forecast-to-2025
Release ID: 472530
Google
RSS